Patrick Rossignol

机构：Inserm, Princess Grace Hospital Centre, Centre Hospitalier Régional et Universitaire de Nancy, French Clinical Research Infrastructure Network, Défaillance Cardiovasculaire Aiguë et Chronique, Université de Lorraine · ORCID：0000-0001-8009-3873

发表论文 477 篇 · 总被引 17918 次 · h-index 67

代表论文

• Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials (2024 · Critical Care · 被引 99)
• Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery (2024 · JAMA · 被引 85)
• SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA (2023 · Nephrology Dialysis Transplantation · 被引 66)
• Spironolactone Effect on Cardiac Structure and Function of Patients with Heart Failure and Preserved Ejection Fraction: A Pooled Analysis of Three Randomized Trials (2022 · European Journal of Heart Failure · 被引 37)
• Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study (2023 · Circulation Heart Failure · 被引 35)
• Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis (2025 · The Lancet · 被引 34)